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Abstract
Background: The objective of this study was to validate physical activity questionnaires for cystic fibrosis (CF)
against accelerometry and cycle ergometry.
Methods: 41 patients with CF (12-42 years) completed the Habitual Activity Estimation Scale (HAES), the 7-Day
Physical Activity Recall questionnaire (7D-PAR) and the Lipid Research Clinics questionnaire (LRC) and performed an
incremental exercise test according to the Godfrey protocol up to volitional fatigue. Time spent in moderate and
vigorous physical activity (MVPA) assessed objectively by accelerometry was related to the time spent in the
respective activity categories by correlation analyses and calculating intraclass correlation coefficients (ICC).
Furthermore, the results of the exercise test were correlated with the results of the questionnaires.
Results: Time spent in the categories ‘hard’,’very hard’ and ‘hard & very hard’ of the 7D-PAR (0.41 < r < 0.56) and
‘active’ (r = 0.33) of the HAES correlated significantly with MVPA. The activity levels of the LRC were not related to
objectively determined physical activity. Significant ICCs were only observed between the 7D-PAR activitiy
categories and MVPA (ICC = 0.40-0.44). Only the LRC showed moderate correlations with the exercise test (Wmax: r
= 0.46, p = 0.002; VO2peak: r = 0.32, p = 0.041).
Conclusions: In conclusion, the activity categories ‘hard’ and ‘very hard’ of the 7D-PAR best reflected objectively
measured MVPA. Since the association was at most moderate, the 7D-PAR may be selected to describe physical
activity within a population. None of the evaluated questionnaires was able to generate valid physical activity data
exercise performance data at the individual level. Neither did any of the questionnaires provide a valid assessment
of aerobic fitness on an invidual level.
Background
Regular physical activity and the training of aerobic fit-
ness have become part of the treatment of cystic fibrosis
(CF) because they contribute to a slower decline in lung
function, a better nutritional status as well as an
improved quality of life [1-3]. Furthermore, physical
activity and aerobic fitness are related [4] and a high
aerobic fitness has been linked to survival in CF [5].
Despite the importance of physical activity for
patients’ health and quality of life in CF, the amount
and intensities of the patients’ activities are not regularly
assessed in the clinical setting and physical activity has
not yet been incorporated in CF registries. This is prob-
ably due to the fact that there are almost no validated
tools to quickly, easily and reliably assess the level of
physical activity in the CF population.
In general, the assessment of physical activity is ham-
pered by difficulties to accurately determine and recall
the type and intensity of all possible activities. Accelero-
metry has therefore been used over the last years to
objectively measure physical activity levels and patterns
in the healthy population and in patients with CF
[1,4,6], and has widely been accepted as a valid tool to
assess physical activity [7] Likewise, peak oxygen uptake
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as surrogate measure of PA [8]. Yet, accelerometry and
cycle ergometry are expensive and time consuming and
require specialized equipment. For the routine assess-
ment of patients’ physical activity in a clinical setting, a
quick and easily accessible tool at low costs is required.
Therefore, questionnaires might be best suited to assess
physical activity. Some of the existing instruments such
as the Lipid Research Clinics (LRC), the Seven Day Phy-
sical Activity Recall (7D-PAR), and the Habitual Activity
Estimation Scale (HAES) questionnaire have been used
and validated in healthy children and adults [9-12] and
have also been employed in patients with CF [2,13,14].
However, in patients with CF a validation against objec-
tive measures of physical activity has only been per-
formed for the HAES in a relatively small group of
young patients [13] and to our knowledge a validation
of questionnaires with respect to aerobic fitness has not
been performed at all.
Therefore, the objective of this study was to validate
commonly used questionnaires for the assessment of
physical activity (HAES, 7D-PAR and LRC) in a larger
group of patients with CF including children and adults
against accelerometry (to assess physical activity beha-
viour) and cycle ergometry (to assess aerobic fitness).
Methods
Participants
In 2006, 41 participants with a proven diagnosis of CF
(12-to 42-years old, 11 adult participants) were recruited
from the CF centre at the University Children’s Hospital
of Wuerzburg, Germany (13 female, 8 male) and from
the CF centre at the Children’s Hospital of Zurich, Swit-
zerland (10 female, 10 male). All patients of the respec-
tive centres with an age of 12 years or higher and a
proven diagnosis of CF were invited to participate in the
study. The diagnosis of CF was based on CF-typical
symptoms and clinical findings and either two patholo-
gical sweat tests or the discovery of CF-relevant muta-
tions in both alleles of the CFTR gene. Patients with
multiresistant bacteria and acute exacerbation at the
time of assessments as defined by published criteria [15]
were excluded from the study. The local ethics commit-
tee approved the study protocol. Written informed con-
sent of the participants and, if applicable, their legal
guardians was obtained after explaining the study proce-
dures to the participants.
Study design
Participants who agreed to take part in the study during
a regular clinical visit wore an accelerometer for 7 con-
secutive days. Two to six weeks later, the participants
returned to the respective CF centres for anthropo-
metric measurements, a lung function test, an
incremental exercise test on a cycle ergometer and the
completion of the HAES, 7D-PAR and LRC physical
activity questionnaires. In a convenient subgroup of 19
participants, accelerometry was repeated four to six
weeks after the first assessment to determine consis-
tency in activity behaviour.
Procedures
Anthropometry and lung function testing
On the day of testing, height and weight were deter-
mined in light clothing without shoes. Pulmonary func-
tion and lung volumes were assessed by spirometry and
bodyplethysmography, respectively (in German subjects
by Masterscreen Body, Jaeger, Wuerzburg, Germany; in
Swiss subjects by Masterlab, Jaeger, Wuerzburg, Ger-
many). Forced expiratory volume in one second (FEV1)
and forced vital capacity (FVC) are reported as %pre-
dicted [16]. Residual volume (RV) is expressed in % of
total lung capacity (TLC).
Assessments of activity behaviour
Accelerometry
The participants wore an accelerometer for 7 days on
their right hip (GT1M, ActiGraph, Pensacola, FL, USA).
Epoch time was set to 60 s as has been employed by
Hebestreit et al. before [4,6]. If the participants’ data
included intervals of zero activity for 10 minutes or
longer, the time period with zero readings was removed
from the data [17]. Participants who did not complete at
least three days of valid recording, including one week-
end day, with at least 9 hours of valid data each day,
were excluded from further analysis [17]. Due to the
fact that there are no validated cut-offs for different
activity levels in CF, we decided to use the cut-offs that
had been used before by Hebestreit et al. [4,6]., Thus,
moderate and vigorous physical activity (MVPA) was
defined as time spent in an activity level of at least 1000
counts per minute, moderate physical activity (MPA)
was classified between 1000 and 1999 counts per min-
ute, and vigorous physical activity (VPA) was assumed if
participants achieved 2000 or more counts per minute.
These cut-offs were based on the following reasoning:
In most validation studies in a healthy population, vali-
dation was performed through activities like running
and walking which are well represented by acceler-
ometers. For such activities, cut-offs around 2000 counts
per minute have been published to discriminate light
from moderate intensities [18,19]. However, if a wide
range of activities was included in the validation process,
a value of 191 counts per minute has been reported as a
cut-off between light and moderate activities [18].
Time spent in each of the activity levels was deter-
mined separately for weekdays and for weekend days.
To determine average MVPA, MPA, and VPA per day,
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with the weekend days’ average times 2 and divided by
7.
Questionnaires
As the questionnaires did not exist in a German version
and all participants were German native speakers, the
7D-PAR, the HAES, and the LRC [8,11,12] were all
translated into German by H Hebestreit. They were
retranslated into English by S Kriemler and were
checked by native speakers to ensure a correct transla-
tion. The German version for the 7D-PAR and the LRC
had used in the past [20], while the German version of
the HAES was first used in this study. For the 7D-PAR,
times spent in the activity categories ‘moderate’, ‘hard’,
and ‘very hard’ were calculated. Likewise, for the HAES
times spent in categories ‘somewhat active’ and ‘active’
were computed. For the LCR, an activity level was
derived for each individual (1 - very low active to 4-
high active). All questionnaires have been validated in a
test-retest analysis before. For the 7D-PAR, Sallis et al.
administered the questionnaire three times during the
validation process to check for reliability and found a
highly significant Pearson correlation coefficient of r =
0.75 for moderate and r = 0.85 for vigorous activities
[11]. In a sample of children and adolescents, they
found a test-retest reliability of r = 0.77 [10]. For the
LRC, Ainsworth et al. administered the questionnaire
two times and found a correlation coefficient of r = 0.85
[8]. The test-retest reliability of the HAES was analyzed
by Wells et al. in patients with CF who found a highly
significant intra-class correlation coefficient ICC = 0.72
[13].
Further details regarding the questionnaires are pro-
vided in the additional material (Additional file 1).
Assessment of aerobic fitness
After familiarizing the patient with the cycle ergometer
(Ergomedic 834 E, Monark, Sweden for the German
subjects and Ergometrics 900, Ergoline, Bitz, Germany
for the Swiss subjects) and the gas sampling equipment,
an incremental exercise test was performed according to
the Godfrey protocol [21]. Work rate was set depending
on the height of the patient: patients with a height
between 120 and 150 cm started with 15 W, patients
taller than 150 cm started with 20 W. Work load was
increased minute-by-minute by 15 W or 20 W, respec-
tively, up to volitional fatigue. Physical working capacity
was determined as the highest work rate performed for
one minute and expressed in % predicted [21]. During
the exercise test, ventilation and gas exchange data were
recorded breath-by-breath using a metabolic cart, and
averaged every 15 seconds (German patients: CPX/D,
MedGraphics, St. Paul, MN, USA; Swiss patients: Cortex
MetaLyzer, Metamax CORTEX Biophysik GmbH,
Leipzig, Germany). Peak oxygen uptake (VO2peak) was
taken as the highest oxygen uptake over two consecutive
15-s intervals during the test and expressed in % pre-
dicted [22]. Maximal power (Wmax) was defined as the
highest workload that could be maintained for a minute.
Statistical analysis
Student-t tests were used to test for differences between
German and Swiss participants, and between female and
male participants with respect to age, anthropometrical
data, pulmonary function measures, lung volumes, exer-
cise performance and physical activity as all variables
were normally distributed. All variables of the accelero-
metry and the questionnaires (except for the LRC) that
assessed time within a certain activity level were
expressed in minutes per day. The time spent in certain
activity levels derived from the 7D-PAR and HAES
questionnaires were related to the time spent in MPA,
VPA and MVPA measured objectively by accelerometry
as well as to exercise performance using Pearson pro-
duct correlation coefficients. Associations between indi-
vidual activity levels determined from the LRC and
physical activity assessed by accelerometry as well as
exercise performance were analysed using Spearman
rank correlations. Validity of the HAES and the 7D-PAR
was further tested calculating intraclass correlations
(ICC) with the accelerometer data. ICC analyses were
used to assess test-retest reliability in the subgroup of
participants with two accelerometry recording periods
with 4 to 6 weeks apart. Furthermore, limits of agree-
ment were calculated in addition to ICC analyses and
the data graphically displayed by a Bland-Altman plot.
All statistical analyses were performed using SPSS 17
(SPSS Inc., Chicago, IL), statistical significance was
assumed at p < 0.05.
Results
Data for the participants of the two countries were
pooled, since there were no significant differences
between the groups for the physical activity variables.
Table 1 summarizes the characteristics of the partici-
pants. No significant differences were found between
Table 1 Patients’ characteristics
Male patients
(n = 18; 4 adults)
Female patients
(n = 23; 7 adults)
Age (years) 15.9 ± 4.5 17.4 ± 6.4
Height (cm) 161.7 ± 10.4 159.1 ± 7.1
Weight (kg) 50.8 ± 12.1 51.7 ± 2.4
FVC (%predicted) 86.8 ± 15.1 89.6 ± 23.2
FEV1 (%predicted) 76.3 ± 20.5 78.0 ± 5.8
RV/TLC (%) 29.5 ± 14.2 34.7 ± 15.5
Values are means ± standard deviations.
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were significantly younger and lighter and showed a sig-
nificantly lower FVC in %predicted than the German
participants (mean age: Swiss participants 14.7 years,
German participants 18.6 years, p = .023; mean weight:
Swiss participants 47.6 kg, German participants 54.8 kg,
p = .046; mean FVC: Swiss participants 80.3%predicted,
German participants 96.0%predicted, p = .010) but did
not show differences in activity measures.
Table 2 summarizes the physical activity determined
by accelerometry and the HAES and 7D-PAR question-
naires as well as the results of the exercise test.
While there was no gender difference in physical
activity assessed by the questionnaires, males spent sig-
nificantly more time than females in the accelerometer
categories VPA and MVPA, but not MPA.
Employing the LRC, 3 males and 6 females were clas-
sified as ‘very low active’, 5 males and 9 females as ‘low
active’, 8 males and 8 females as ‘moderately active’, and
2 males but no female as ‘very active’.
Table 3 summarizes the relationships between physical
activity as determined by accelerometry and physical
activity estimated from questionnaires.
Significant correlations were observed between MPA
and MVPA measured by accelerometry and the activity
categories ‘hard’, ‘very hard’, ‘moderate & hard & very
hard’,a n d ’ hard & very hard activity’ reported in the
7D-PAR. For VPA a significant correlation was only evi-
dent with the category ‘very hard’ of the 7D-PAR. The
category’active’ of the HAES also showed a moderate
but significant correlation with MPA and MVPA, but
not with VPA. There was no association between physi-
cal activity measured by accelerometry and the indivi-
dual’s activity level determined by the LCR.
The results of the exercise test (Wmax and VO2peak)
did not correlate with the results of the HAES and 7D-
PAR (data not shown). However, the individuals’ activity
levels derived from the LRC showed a moderate correla-
tion with Wmax (r = 0.46, p = 0.002) and a weak corre-
lation with VO2peak (r = 0.32, p = 0.041).
The ICC-analyses of the accelerometer data and the
d a t ad e r i v e df r o mt h e7 D - P A Ra n dH A E S( T a b l e4 )
revealed that only the 7D-PAR categories ‘hard’, ‘very
hard’,a n d‘hard & very hard’ significantly reflected
objectively measured PA. None of the HAES activity
categories showed significant ICCs with the PA cate-
gories determined by accelerometry.
Significant correlations were observed between MPA
and MVPA measured by accelerometry and the activity
categories ‘hard’, ‘very hard’, ‘moderate & hard & very
hard’,a n d ’ hard & very hard activity’ reported in the
7D-PAR. For VPA a significant correlation was only evi-
dent with the category ‘very hard’ of the 7D-PAR. The
category’active’ of the HAES also showed a moderate
but significant correlation with MPA and MVPA, but
not with VPA. There was no association between physi-
cal activity measured by accelerometry and the indivi-
dual’s activity level determined by the LCR.
The results of the exercise test (Wmax and VO2peak)
did not correlate with the results of the HAES and 7D-
Table 2 Time spent in certain physical activity categories as derived from questionnaires and accelerometry, and
physical fitness as determined by cycle ergometry for male and female participants of the study
Instrument Variable Male patients
(n = 18; 4 adults)
Female patients
(n = 23; 7 adults)
Physical activity
7D-PAR moderate (min/d) 101.1 ± 117.6 114.7 ± 126.1
hard (min/d) 48.1 ± 60.8 50.9 ± 68.8
very hard (min/d) 38.5 ± 51.8 20.3 ± 26.8
Moderate & hard & very hard (min/d) 187.7 ± 193.2 185.8 ± 177.1
hard & very hard (min/d) 86.6 ± 102.3 71.2 ± 77.4
HAES active (min/d) 137.0 ± 132.2 136.5 ± 137.6
somewhat active & active (min/d) 358.8 ± 185.6 445.3 ± 202.5
Accelerometry MPA (min/d) 49.5 ± 17.8 42.1 ± 29.7
VPA (min/d) 47.7 ± 24.7 28.6 ± 14.1 **
MVPA (min/d) 97.2 ± 36.5 70.8 ± 35.4 *
Physical fitness
Cycle ergometry Wmax (% predicted) 112.5 ± 22.1 103.5 ± 15.1
VO2peak (% predicted) 88.5 ± 16.3 81.0 ± 13.3
Values are mean ± standard deviation.
Abbreviations: 7D-PAR - seven day physical activity recall questionnaire; HAES - habitual activity estimation scale; min/d - minutes per day; MPA - moderate
physical activity; VPA - vigorous physical activity; MVPA - moderate and vigorous physical activity; Wmax - maximal power during cycle ergometry; VO2peak -
peak oxygen uptake.
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levels derived from the LRC showed a moderate correla-
tion with Wmax (r = 0.46, p = 0.002) and a weak corre-
lation with VO2peak (r = 0.32, p = 0.041).
The ICC-analyses of the accelerometer data and the
d a t ad e r i v e df r o mt h e7 D - P A Ra n dH A E S( T a b l e4 )
revealed that only the 7D-PAR categories ‘hard’, ‘very
hard’,a n d‘hard & very hard’ significantly reflected
objectively measured PA. None of the HAES activity
categories showed significant ICCs with the PA cate-
gories determined by accelerometry.
A test-retest analysis in the subgroup of 19 partici-
pants showed a moderate to strong reproducibility of
the time an individual patient spent in the accelerometer
categories, MPA, VPA, and MVPA with higher ICCs for
MPA and MVPA than for VPA (MPA: ICC = 0.804, p =
0.000; VPA: ICC = 0.578, p = 0.004; MVPA: ICC =
0.702, p = 0.000). A Bland-Altman plot (see Figure 1)
further illustrates the test-retest analysis of the three
categories MPA, VPA, and MVPA. Limits of agreement
were, 56.6/-46.8 min/day for MPA, 32.9/28.4 min/dayfor
VPA and 36.4/-31.1 min/day for MVPA.
Discussion
The aim of this study was to evaluate questionnaires
assessing physical activity by comparing them to objec-
tively measured physical activity. Measures of physical
activity derived from the 7D-PAR as well as the HAES
showed significant correlations to physical activity
assessed by accelerometry. In the validity analyses based
on ICCs, though, only the physical activity calculated
from the 7D-PAR categories ‘hard’, ‘very hard’ and “hard
& very hard” significantly reflected objectively measured
physical activity. To our knowledge, this study is the
first to validate the 7D-PAR against accelerometry in a
group of patients with CF.
With regard to the HAES, we were able to reproduce
the significant Pearson product correlations reported by
Wells et al. [13]. However, in contrast to our findings
(Table 4), Wells et al. [13] found a significant ICC of
0.44 by relating accelerometry data to the ‘total activity’
assessed by the HAES, which combined the categories
‘somewhat active’ and ‘very active’ in a group of 14
rather healthy (FEV1 > 70%pred) adolescent patients
with a mean age of 16 years.
Table 3 Associations between objectively measured physical activity and physical activity assessed by questionnaires
MPA (min/d) VPA
(min/d)
MVPA
(min/d)
7D-PAR moderate (min/d) r = .167
p = .298
r = .-038
p = .816
r = .090
p = .577
hard (min/d) r = .661
p = .000
r = .118
p = .461
r = .508
p = .001
very hard (min/d) r = .340, p = .030 r = .321, p = .041 r = .409, p = .008
Moderate & hard & very
hard (min/d)
r = .421, p = .006 r = .088, p = .584 r = .330, p = .035
hard & very hard (min/d) r = .639, p = .000 r = .233, p = .143 r = .558, p = .000
HAES active (min/d) r = .403, p = .009 r = .101, p = .528 r = .326, p = .037
somewhat active & active (min/d) r = .092
p = .566
r = .003, p = .983 r = -.102, p = .522
LRC activity category r = -.056, p = .728 r = .017, p = .971 r = -.007, p = .965
Values are Pearson product correlation coefficients (HAES; 7D-PAR) or Spearman rank correlation coefficients (LRC), and the respective probability of a type I error
(p). For further abbreviations, see legend Table 2.
Table 4 Intraclass correlation coefficients (ICC) relating measures of PA derived from the 7D-PAR and the HAES
questionnaires to PA measured by accelerometry
MPA (min/d) VPA
(min/d)
MVPA
(min/d)
7D-PAR moderate (min/d) ICC = .066, p = .338 ICC = .097, p = .374 ICC = -.013, p = .532
hard (min/d) ICC = .448, p = .001 ICC = .071, p = .328 ICC = .443, p = .002
very hard (min/d) ICC = .306, p = .024 ICC = .267, p = .044 ICC = .408, p = .004
Moderate & hard & very hard (min/d) ICC = .114, p = .235, ICC = .020, p = .449 ICC = .132, p = .203
hard & very hard (min/d) ICC = .337, p = .015 ICC = .107, p = .250 ICC = .404, p = .004
HAES active (min/d) ICC = .147, p = .177 ICC = .032, p = .421 ICC = .171, p = .292,
somewhat active & active (min/d) ICC = .023, p = .442 ICC = -.022, p = .555 ICC = .001, p = .497
For abbreviations, see legend Table 2.
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that the intensity of activities within each category is
comparable between the two modes. According to the
ACSM guidelines [9], MPA equals 3.0-6.0 metabolic
units (MET) and VPA is seen as an activity > 6.0 METs;
thus MVPA would be defined as an activity requiring
more than 3 METs. In the 7D-PAR, the activity category
‘moderate’ reflects 3.0 to 4.9 METs, ‘hard’ equals 5.0 to
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Figure 1 Bland-Altman plots of the test-retest accelerometry data for each activity category; A: Moderate physical activity (MPA), B:
Vigorous physical activity (VPA) C: Moderate and vigorous physical activity (MVPA).
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more METs [11]. In the description of the HAES, no
MET values are mentioned for the corresponding activ-
ity levels. When comparing the examples given to help
the participants to categorize their activities to the Com-
pendium of Physical Activities [9], which defines MET
intensities for the respective activities, it seems that
MVPA is solely represented by the category ‘very active’.
By combining the categories ‘somewhat active’ and ‘very
active’ of the HAES (=total activity) light activities are
included which should result in a higher amount of phy-
sical activity than MVPA determined by accelerometry.
This is exactly what we found (Table 2) and might
explain why there were no significant ICCs between
total activity determined from the HAES and MVPA
measured by accelerometry. Furthermore, in contrast to
the HAES, the 7D-PAR asks for separate reporting of
moderate, hard and very hard physical activity. There-
fore the 7D-PAR may allow a better recollection of
activities leading to more useful data when compared to
accelerometry.
Chinapaw et al. [23] as well as Boon et al. [24] showed
that questionnaires tend to overestimate activity time in
a certain category in comparison to accelerometry in
healthy adolescents and adults. This finding was repro-
duced in our study in patients with CF with regard to
the HAES and the 7D-PAR. Nonetheless, the difference
between questionnaire-reported and accelerometer-
assessed physical activity may have other reasons. Trost
et al. [25] demonstrated that not every activity can be
adequately recorded by accelerometry and that especially
free-living activities are underestimated in their energy
expenditure and their intensity by accelerometry. This is
especially true for physical activity predominantly per-
formed by the upper body and physical activity includ-
ing gliding activities on a vehicle [26]. Hence, the
difference of daily habitual physical activity between
questionnaires and accelerometers might seem larger in
the analysis than it actually is in real life.
None of the physical activity questionnaires (7D-PAR,
HAES, and LRC) used in this study was able to detect
the gender difference in MVPA measured by accelero-
metry which has also been previously reported for
healthy individuals and those with CF [1].
In patients with CF, regular physical activity is
linked to a better lung health, physical fitness, nutri-
tional status and quality of life [3,5,27,28]. Monitoring
physical activity is thus important to identify patients
who may benefit from activity interventions. As our
results showed, only the 7D-PAR and the HAES were
able to reflect objectively measured physical activity.
However, these questionnaiers are not measuring phy-
sical activity precise enough to obtain data which
could be used for individual counselling. Thus, on an
individual basis, other means such as accelerometry
are required.
Whereas the LRC activity levels did not reflect PA
measured by accelerometer, a moderate correlation was
observed with Wmax and VO2peak. This finding is in
line with the original validation study of the LRC which
showed a significant association of the LRC activity
levels with VO2peak but not with physical activity mea-
sured by accelerometry in a healthy adult population
[8,29,30]. In contrast to the individual LRC activity
levels, neither the physical activity derived from the 7D-
PAR or from the HAES questionnaire correlated with
measures of physical fitness. Other studies have shown
some positive relationship between VO2peak and PA
determined by the 7D-PAR in adults, although the asso-
ciation was not always significant (for example [31]).
Hebestreit et al. [4] showed that objectively measured
physical activity is related to aerobic fitness which is
related to survival in CF [5]. At least some of the effects
of physical activity on health in CF may be moderated
by an increase in aerobic fitness. Here, vigorous activ-
ities are most effective. The inability of the 7D-PAR and
the HAES to reflect aerobic fitness may be attributed to
the fact that vigorous activities were not captured as
well as moderate activities (Tables 3 and 4). Although
the activity level derived from the LRC questionnaire
was correlated with aerobic fitness, the association was
not striong enough to be informative on an individual
level. The gold standard for determining aerobic fitness
is the measurement of VO2peak.
There are some limitations of the present study. First,
the accelerometry was performed 2-6 weeks prior to
completing the questionnaires. This approach might
have weakened the observed relationships between phy-
sical activity measured by accelerometry and physical
activity assessed by questionnaires. However, as shown
in the test-retest analysis and in Figure 1, there was a
high consistency of activity behaviour suggesting high
stability of physical activity behaviour over a period of
2-6 weeks. Furthermore, as patients with CF are typi-
cally seen at their CF centre in intervals of 4-12 weeks
the schedule of data collection best reflects the situation
of centre care where physical activity may be assessed in
intervals of at least 3 months. Second, in contrast to
other studies, the 7D-PAR was not interviewer-adminis-
tered in our study but employed as questionnaire. How-
ever, one investigator was always present during the
completion of questionnaires and ready to answer any
question raised by the participants. This rationale was
chosen as we wanted to identify and test questionnaires
to be used in a CF centre setting, where interview-admi-
nistered questionnaires would probably not be useful for
an every day usage. After filling in the questionnaire, the
investigators checked the questionnaires for plausibility
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pants included in our study were in a relatively good
clinical condition (Table 1). Likewise, the proportion of
adult participants (i.e. 25%) in our sample was relatively
small. Fourth, we used the cut-offs established by
Hebestreit et al. [4,6] to determine activity categories.
Within accelerometer research a wide variety of cut-offs
has been published. When using different cut-offs, the
ICC results may also change. Fifth, due to the transla-
tion of the questionnaires into German, cultural and
translational matters may result in a slightly different
understanding of some questions.
Conclusions
In summary, the information on a patient’s physical
activity derived from questionnaires is hampered by
only moderate relationships to the accelerometer mea-
surements. The highest validity based on ICC analyses
was observed for the 7D-PARs categories ‘hard’, ‘very
hard’ and ‘hard & very hard’, and the latter showed the
strongest Pearson product correlation with MVPA.
Therefore, the summed categories ‘hard & very hard’
might be best suited to describe physical activity in
patients with CF. However, even the 7D-PAR could pro-
vide only rough estimates of an individual’s objectively
measured physical activity. None of the physical activity
questionnaires was precise enough to be useful for indi-
vidual counselling. For this purpose, additional objective
measures such as accelerometry are required. For epide-
miological studies and registries, however, a physical
activity questionnaire might be sufficient to describe a
CF population’s activity behaviour. Further studies
should explore the generalizability of our findings by
including a more heterogeneous CF population, i.e.
more adults and more participants with severe disease.
Abbreviations: 7D-PAR, seven day physical activity
recall questionnaire; CF, cystic fibrosis; FEV1, forced
expiratory volume in 1 second; FVC, forced vital capa-
city; HAES, habitual activity estimation scale; ICC, intra-
class correlation coefficient; LRC, lipid research clinics
questionnaire; MET, metabolic unit; MPA, moderate
physical activity; MVPA, moderate to vigorous physical
activity; RV, residual volume; TLC, total lung capacity;
VPA, vigorous physical activity
Additional material
Additional file 1: Detailed description of physical activity
questionnaires.
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